Concentrix (NASDAQ:CNXC – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity Group in a note issued to investors on Wednesday, Benzinga reports. They currently have a $45.00 price target on the stock. Canaccord Genuity Group’s target price would indicate a potential upside of 75.51% from the stock’s previous close.
Other equities research analysts have also recently issued research reports about the company. Barrington Research cut their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Robert W. Baird cut their price target on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Zacks Research raised shares of Concentrix from a “strong sell” rating to a “hold” rating in a report on Monday, August 31st. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a report on Friday, July 24th. Finally, Bank of America cut their price target on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $32.75.
Check Out Our Latest Research Report on Concentrix
Concentrix Trading Up 3.1%
Concentrix (NASDAQ:CNXC – Get Free Report) last announced its quarterly earnings data on Tuesday, September 29th. The company reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.71 by $0.21. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.48 billion. During the same quarter last year, the business posted $2.78 EPS. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.970-11.090 EPS and its Q4 2026 guidance at 2.860-2.980 EPS. Analysts expect that Concentrix will post 9.67 EPS for the current fiscal year.
Hedge Funds Weigh In On Concentrix
A number of institutional investors have recently made changes to their positions in CNXC. Northwestern Mutual Wealth Management Co. acquired a new stake in Concentrix in the second quarter worth $25,000. Nykredit A S purchased a new position in Concentrix during the 2nd quarter worth approximately $29,000. Webster Bank N. A. purchased a new position in Concentrix during the 1st quarter worth approximately $41,000. Rothschild Investment LLC grew its position in Concentrix by 52.0% during the 4th quarter. Rothschild Investment LLC now owns 1,146 shares of the company’s stock worth $48,000 after purchasing an additional 392 shares in the last quarter. Finally, Hantz Financial Services Inc. grew its position in Concentrix by 244.0% during the 4th quarter. Hantz Financial Services Inc. now owns 1,727 shares of the company’s stock worth $72,000 after purchasing an additional 1,225 shares in the last quarter. 90.34% of the stock is owned by institutional investors and hedge funds.
Key Stories Impacting Concentrix
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: Concentrix reported third-quarter adjusted EPS of $2.92, exceeding analysts’ $2.71 consensus and increasing from $2.78 a year earlier. The company also exceeded its profitability guidance and generated record third-quarter operating free cash flow of $268 million, including $218 million in adjusted free cash flow. Concentrix Reports Third Quarter 2026 Results
- Positive Sentiment: The board raised the quarterly dividend 2.8% to $0.37 per share, or $1.48 annualized. The dividend provides a yield of approximately 5.6%, which may support investor interest in the stock. Concentrix Dividend and Stock Information
- Positive Sentiment: Canaccord Genuity reaffirmed its “buy” rating and maintained a $45 price target, implying substantial upside from recent trading levels. Management also expects new-business revenue to exceed $6 billion in 2027 and is targeting net leverage of 2.2 times in that year.
- Neutral Sentiment: Concentrix issued full-year fiscal 2026 EPS guidance of $10.97–$11.09, above the $10.89 analyst consensus. However, its $9.8–$9.9 billion revenue outlook is below the $10.0 billion consensus, indicating stronger profitability but softer sales expectations.
- Negative Sentiment: Third-quarter revenue was $2.45 billion, below the $2.48 billion consensus and down 1.2% year over year. The mixed results raised concerns about demand and the company’s transition toward AI-enabled services. Concentrix Stock Falls After Earnings as AI Transition Weighs on Revenue
- Negative Sentiment: Fourth-quarter guidance was notably below expectations: EPS of $2.86–$2.98 versus a $3.08 consensus, and revenue of $2.4–$2.5 billion versus $2.5 billion expected. This weaker near-term outlook is the primary reason CNXC has moved lower despite the quarterly EPS beat.
About Concentrix
Concentrix Corporation is a global technology and services company that helps organizations manage customer experience, business operations and digital transformation. Its offerings include customer care, technical support, sales and marketing services, back-office support, analytics, artificial intelligence and automation solutions.
The company serves clients across industries such as technology and consumer electronics, retail, banking and financial services, healthcare, communications and media, travel, and automotive.
See Also
- Five stocks we like better than Concentrix
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
